Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

IDENTIFICATION OF IMMUNOGENIC MHC CLASS II PEPTIDES FOR IMMUNE-BASED THERAPY

Application EP-3791891-A1

European Patent Office

IDENTIFICATION OF IMMUNOGENIC MHC CLASS II PEPTIDES FOR IMMUNE-BASED THERAPY

Application EP-3169354-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.